HEADER DNA BINDING PROTEIN 02-MAR-23 8CPI TITLE CRYSTAL STRUCTURE OF PPAR GAMMA (PPARG) IN COMPLEX WITH WY-14643 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: PPAR-GAMMA,NUCLEAR RECEPTOR SUBFAMILY 1 GROUP C MEMBER 3; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PPARG, NR1C3; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PNIC28-BSA4 KEYWDS PPARG, ALLOSTERIC INHIBITOR, ORTHOSTERIC INHIBITOR, STRUCTURAL KEYWDS 2 GENOMICS, STRUCTURAL GENOMICS CONSORTIUM, SGC, DNA BINDING PROTEIN EXPDTA X-RAY DIFFRACTION AUTHOR A.CHAIKUAD,D.MERK,S.KNAPP,STRUCTURAL GENOMICS CONSORTIUM (SGC) REVDAT 2 19-JUL-23 8CPI 1 JRNL REVDAT 1 12-JUL-23 8CPI 0 JRNL AUTH S.ARIFI,J.A.MARSCHNER,J.POLLINGER,L.ISIGKEIT,P.HEITEL, JRNL AUTH 2 A.KAISER,L.OBESER,G.HOFNER,E.PROSCHAK,S.KNAPP,A.CHAIKUAD, JRNL AUTH 3 J.HEERING,D.MERK JRNL TITL TARGETING THE ALTERNATIVE VITAMIN E METABOLITE BINDING SITE JRNL TITL 2 ENABLES NONCANONICAL PPAR GAMMA MODULATION. JRNL REF J.AM.CHEM.SOC. V. 145 14802 2023 JRNL REFN ESSN 1520-5126 JRNL PMID 37385602 JRNL DOI 10.1021/JACS.3C03417 REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0267 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.38 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 3 NUMBER OF REFLECTIONS : 19784 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.225 REMARK 3 R VALUE (WORKING SET) : 0.222 REMARK 3 FREE R VALUE : 0.282 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1058 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.16 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1425 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 100.0 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE SET COUNT : 75 REMARK 3 BIN FREE R VALUE : 0.3600 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2224 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 42 REMARK 3 SOLVENT ATOMS : 44 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 69.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.21000 REMARK 3 B22 (A**2) : 1.21000 REMARK 3 B33 (A**2) : -2.43000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.222 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.206 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.173 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.647 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.958 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.926 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2307 ; 0.011 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 2273 ; 0.001 ; 0.016 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3111 ; 1.159 ; 1.641 REMARK 3 BOND ANGLES OTHERS (DEGREES): 5247 ; 1.181 ; 1.595 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 276 ; 7.553 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 108 ;34.450 ;24.352 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 443 ;16.116 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 8 ;23.756 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 300 ; 0.059 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2688 ; 0.010 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 488 ; 0.002 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1107 ; 3.147 ; 5.225 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 1108 ; 3.146 ; 5.231 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 1382 ; 4.569 ; 7.828 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 1383 ; 4.570 ; 7.831 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1200 ; 3.593 ; 5.758 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 1201 ; 3.591 ; 5.763 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 1730 ; 5.506 ; 8.491 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): 2565 ; 7.866 ;62.749 REMARK 3 LONG RANGE B OTHER ATOMS (A**2): 2566 ; 7.869 ;62.784 REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 201 A 477 REMARK 3 ORIGIN FOR THE GROUP (A): 28.9874 -16.5170 67.6961 REMARK 3 T TENSOR REMARK 3 T11: 0.1044 T22: 0.0608 REMARK 3 T33: 0.0751 T12: -0.0019 REMARK 3 T13: -0.0616 T23: -0.0095 REMARK 3 L TENSOR REMARK 3 L11: 1.6760 L22: 3.6847 REMARK 3 L33: 1.8909 L12: -0.4904 REMARK 3 L13: 0.1257 L23: 1.3262 REMARK 3 S TENSOR REMARK 3 S11: -0.0168 S12: -0.1358 S13: 0.0278 REMARK 3 S21: 0.3516 S22: 0.1749 S23: -0.4991 REMARK 3 S31: 0.0701 S32: 0.2615 S33: -0.1582 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 8CPI COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 02-MAR-23. REMARK 100 THE DEPOSITION ID IS D_1292128979. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 15-DEC-21 REMARK 200 TEMPERATURE (KELVIN) : 100.0 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.00002 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 6M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : AIMLESS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20906 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 46.380 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 100.0 REMARK 200 DATA REDUNDANCY : 11.80 REMARK 200 R MERGE (I) : 0.04500 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 23.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.17 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : 12.50 REMARK 200 R MERGE FOR SHELL (I) : 1.08500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.95 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 1.6M AMMONIUM SULFATE, 0.1M TRIS 8.0, REMARK 280 VAPOR DIFFUSION, SITTING DROP, TEMPERATURE 293.15K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 78.63200 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 32.79750 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 32.79750 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 117.94800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 32.79750 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 32.79750 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 39.31600 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 32.79750 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 32.79750 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 117.94800 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 32.79750 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 32.79750 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 39.31600 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 78.63200 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 LEU A 393 48.52 -89.39 REMARK 500 THR A 459 -13.42 -149.40 REMARK 500 ASP A 475 74.42 -105.00 REMARK 500 LEU A 476 61.77 -117.67 REMARK 500 REMARK 500 REMARK: NULL DBREF 8CPI A 203 477 UNP P37231 PPARG_HUMAN 231 505 SEQADV 8CPI SER A 201 UNP P37231 EXPRESSION TAG SEQADV 8CPI MET A 202 UNP P37231 EXPRESSION TAG SEQRES 1 A 277 SER MET GLN LEU ASN PRO GLU SER ALA ASP LEU ARG ALA SEQRES 2 A 277 LEU ALA LYS HIS LEU TYR ASP SER TYR ILE LYS SER PHE SEQRES 3 A 277 PRO LEU THR LYS ALA LYS ALA ARG ALA ILE LEU THR GLY SEQRES 4 A 277 LYS THR THR ASP LYS SER PRO PHE VAL ILE TYR ASP MET SEQRES 5 A 277 ASN SER LEU MET MET GLY GLU ASP LYS ILE LYS PHE LYS SEQRES 6 A 277 HIS ILE THR PRO LEU GLN GLU GLN SER LYS GLU VAL ALA SEQRES 7 A 277 ILE ARG ILE PHE GLN GLY CYS GLN PHE ARG SER VAL GLU SEQRES 8 A 277 ALA VAL GLN GLU ILE THR GLU TYR ALA LYS SER ILE PRO SEQRES 9 A 277 GLY PHE VAL ASN LEU ASP LEU ASN ASP GLN VAL THR LEU SEQRES 10 A 277 LEU LYS TYR GLY VAL HIS GLU ILE ILE TYR THR MET LEU SEQRES 11 A 277 ALA SER LEU MET ASN LYS ASP GLY VAL LEU ILE SER GLU SEQRES 12 A 277 GLY GLN GLY PHE MET THR ARG GLU PHE LEU LYS SER LEU SEQRES 13 A 277 ARG LYS PRO PHE GLY ASP PHE MET GLU PRO LYS PHE GLU SEQRES 14 A 277 PHE ALA VAL LYS PHE ASN ALA LEU GLU LEU ASP ASP SER SEQRES 15 A 277 ASP LEU ALA ILE PHE ILE ALA VAL ILE ILE LEU SER GLY SEQRES 16 A 277 ASP ARG PRO GLY LEU LEU ASN VAL LYS PRO ILE GLU ASP SEQRES 17 A 277 ILE GLN ASP ASN LEU LEU GLN ALA LEU GLU LEU GLN LEU SEQRES 18 A 277 LYS LEU ASN HIS PRO GLU SER SER GLN LEU PHE ALA LYS SEQRES 19 A 277 LEU LEU GLN LYS MET THR ASP LEU ARG GLN ILE VAL THR SEQRES 20 A 277 GLU HIS VAL GLN LEU LEU GLN VAL ILE LYS LYS THR GLU SEQRES 21 A 277 THR ASP MET SER LEU HIS PRO LEU LEU GLN GLU ILE TYR SEQRES 22 A 277 LYS ASP LEU TYR HET WY1 A 501 21 HET WY1 A 502 21 HETNAM WY1 2-({4-CHLORO-6-[(2,3-DIMETHYLPHENYL)AMINO]PYRIMIDIN-2- HETNAM 2 WY1 YL}SULFANYL)ACETIC ACID FORMUL 2 WY1 2(C14 H14 CL N3 O2 S) FORMUL 4 HOH *44(H2 O) HELIX 1 AA1 ASN A 205 PHE A 226 1 22 HELIX 2 AA2 THR A 229 THR A 238 1 10 HELIX 3 AA3 ASP A 251 ILE A 262 1 12 HELIX 4 AA4 GLU A 276 SER A 302 1 27 HELIX 5 AA5 GLY A 305 LEU A 309 5 5 HELIX 6 AA6 ASP A 310 ALA A 331 1 22 HELIX 7 AA7 SER A 332 MET A 334 5 3 HELIX 8 AA8 ARG A 350 SER A 355 1 6 HELIX 9 AA9 MET A 364 ALA A 376 1 13 HELIX 10 AB1 ASP A 380 LEU A 393 1 14 HELIX 11 AB2 ASN A 402 HIS A 425 1 24 HELIX 12 AB3 GLN A 430 LYS A 458 1 29 HELIX 13 AB4 HIS A 466 LYS A 474 1 9 SHEET 1 AA1 3 PHE A 247 ILE A 249 0 SHEET 2 AA1 3 GLY A 346 THR A 349 1 O PHE A 347 N ILE A 249 SHEET 3 AA1 3 GLY A 338 ILE A 341 -1 N VAL A 339 O MET A 348 CISPEP 1 LYS A 358 PRO A 359 0 -9.05 CRYST1 65.595 65.595 157.264 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015245 0.000000 0.000000 0.00000 SCALE2 0.000000 0.015245 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006359 0.00000